The projected effect of risk factor reduction on Alzheimer's disease prevalence

The Lancet Neurology

Volumn 10, Issue 9, 2011, Pages 819-828

  Barnes, Deborah E ^a,c   Yaffe, Kristine ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; COGNITIVE DEFECT; DEPRESSION; DIABETES MELLITUS; EDUCATION; HUMAN; HYPERTENSION; IMMOBILIZATION; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; UNITED STATES;

ALZHEIMER DISEASE; DEPRESSION; DIABETES MELLITUS; HUMANS; HYPERTENSION; LIFE STYLE; MOTOR ACTIVITY; OBESITY; PREVALENCE; RISK FACTORS; SMOKING;

EID: 80051669619     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70072-2     Document Type: Review

References (101)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007, 3:186-191.
2. Alzheimer's disease facts and figures (accessed Jan 10, 2011). http://www.alz.org/documents_custom/report_alzfactsfigures2010.pdf.
3. O'Brien JT, Burns A Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol 2010, published online Nov 18. 10.1177/0269881110387547.
4. Green RC, Schneider LS, Amato DA, et al. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA 2009, 302:2557-2564.
5. Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010, 304:1903-1911.
6. Daviglus ML, Bell CC, Berrettini W, et al. National Institutes of Health State-of-the-Science Conference statement: preventing Alzheimer disease and cognitive decline. Ann Internal Med 2010, 153:176-181.
7. Mokdad AH, Marks JS, Stroup DF, Gerberding JL Actual causes of death in the United States, 2000. JAMA 2004, 291:1238-1245.
8. McGuinness B, Todd S, Passmore P, Bullock R Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2009, 4. CD004034.
9. Profenno LA, Porsteinsson AP, Faraone SV Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 2010, 67:505-512.
10. Levin ML The occurrence of lung cancer in man. Acta Unio Internationalis Contra Cancrum 1953, 9:531-541.
11. Benichou J A review of adjusted estimators of attributable risk. Stat Methods Med Res 2001, 10:195-216.
12. Darrow LA, Steenland NK Confounding and bias in the attributable fraction. Epidemiology 2011, 22:53-58.
13. Ruckinger S, von Kries R, Toschke AM An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors. BMC Med Res Methodol 2009, 9:7.
14. Gefeller O Comparison of adjusted attributable risk estimators. Stat Med 1992, 11:2083-2091.
15. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006, 5:64-74.
16. Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol 2008, 585:97-108.
17. Kopf D, Frölich L Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials. J Alzheimers Dis 2009, 16:677-685.
18. Lu FP, Lin KP, Kuo HK Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One 2009, 4:e4144.
19. Grimley EV, Areosa SA Effect of the treatment of type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev 2002, 4. CD003804.
20. Ligthart SA, Moll van Charante EP, Van Gool WA, Richard E Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review. Vasc Health Risk Manag 2010, 6:775-785.
21. Shaw JE, Sicree RA, Zimmet PZ Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
22. Wild S, Roglic G, Green A, Sicree R, King H Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
23. Vital and health statistics: summary health statistics for US adults: National Health Interview Survey, 2009 2010, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, MD.
24. Kennelly SP, Lawlor BA, Kenny RA Blood pressure and dementia-a comprehensive review. Ther Adv Neurol Disord 2009, 2:241-260.
25. Purnell C, Gao S, Callahan CM, Hendrie HC Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature. Alzheimer Dis Assoc Disord 2009, 23:1-10.
26. Qiu C, Winblad B, Fratiglioni L The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005, 4:487-499.
27. Kennelly SP, Lawlor BA, Kenny RA Blood pressure and the risk for dementia: a double edged sword. Ageing Res Rev 2009, 8:61-70.
28. Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008, 7:683-689.
29. Wang JG, Staessen JA, Birkenhager WH Antihypertensive treatment and prevention of stroke and dementia. Semin Cerebrovasc Dis Stroke 2003, 2003:155-164.
30. Shah K, Qureshi SU, Johnson M, Parikh N, Schulz PE, Kunik ME Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review. Am J Geriatr Pharmacother 2009, 7:250-261.
31. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001, 322:1447-1451.
32. Freitag MH, Peila R, Masaki K, et al. Midlife pulse pressure and incidence of dementia: the Honolulu-Asia Aging Study. Stroke 2006, 37:33-37.
33. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005, 64:277-281.
34. Wu C, Zhou D, Wen C, Zhang L, Como P, Qiao Y Relationship between blood pressure and Alzheimer's disease in Linxian County, China. Life Sci 2003, 72:1125-1133.
35. Yamada M, Kasagi F, Sasaki H, Masunari N, Mimori Y, Suzuki G Association between dementia and midlife risk factors: the Radiation Effects Research Foundation Adult Health Study. J Am Geriatr Soc 2003, 51:410-414.
36. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
37. Health: Unites States, 2010: with special feature on death and dying 2011, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD.
38. International Data Base (IDB), 2010 (accessed Jan 19, 2011). http://www.census.gov/ipc/www/idb/region.php.
39. Beydoun MA, Beydoun HA, Wang Y Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 2008, 9:204-218.
40. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R Measures of adiposity and dementia risk in elderly persons. Arch Neurol 2007, 64:392-398.
41. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009, 66:336-342.
42. Barnes DE, Covinsky KE, Whitmer RA, Kuller LH, Lopez OL, Yaffe K Predicting risk of dementia in older adults: the late-life dementia risk index. Neurology 2009, 73:173-179.
43. Dahl AK, Lopponen M, Isoaho R, Berg S, Kivela SL Overweight and obesity in old age are not associated with greater dementia risk. J Am Geriatr Soc 2008, 56:2261-2266.
44. Knopman DS, Edland SD, Cha RH, Petersen RC, Rocca WA Incident dementia in women is preceded by weight loss by at least a decade. Neurology 2007, 69:739-746.
45. Beydoun MA, Lhotsky A, Wang Y, et al. Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease. Am J Epidemiol 2008, 168:1179-1189.
46. Kelly T, Yang W, Chen CS, Reynolds K, He J Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008, 32:1431-1437.
47. Flegal KM, Carroll MD, Ogden CL, Curtin LR Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
48. Jorm AF History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry 2001, 35:776-781.
49. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006, 63:530-538.
50. Butters MA, Becker JT, Nebes RD, et al. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry 2000, 157:1949-1954.
51. Doraiswamy PM, Krishnan KR, Oxman T, et al. Does antidepressant therapy improve cognition in elderly depressed patients?. J Gerontology A Biol Sci Med Sci 2003, 58:M1137-M1144.
52. Nebes RD, Pollock BG, Houck PR, et al. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res 2003, 37:99-108.
53. Gallassi R, Di Sarro R, Morreale A, Amore M Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy. J Affective Disord 2006, 91:243-250.
54. Portella MJ, Marcos T, Rami L, Navarro V, Gasto C, Salamero M Residual cognitive impairment in late-life depression after a 12-month period follow-up. Int J Geriatr Psychiatry 2003, 18:571-576.
55. Knegtering H, Eijck M, Huijsman A Effects of antidepressants on cognitive functioning of elderly patients: a review. Drugs Aging 1994, 5:192-199.
56. Beekman AT, Copeland JR, Prince MJ Review of community prevalence of depression in later life. Br J Psychiatry 1999, 174:307-311.
57. Djernes JK Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand 2006, 113:372-387.
58. Kessler RC, Birnbaum HG, Shahly V, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety 2010, 27:351-364.
59. Kessler RC, Birnbaum H, Bromet E, Hwang I, Sampson N, Shahly V Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychol Med 2010, 40:225-237.
60. Hamer M, Chida Y Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med 2009, 39:3-11.
61. Rolland Y, Abellan van Kan G, Vellas B Physical activity and Alzheimer's disease: from prevention to therapeutic perspectives. J Am Med Dir Assoc 2008, 9:390-405.
62. Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 2008, 3. CD005381.
63. Guthold R, Ono T, Strong KL, Chatterji S, Morabia A Worldwide variability in physical inactivity a 51-country survey. Am J Prev Med 2008, 34:486-494.
64. Middleton LE, Barnes DE, Lui LY, Yaffe K Physical activity over the life course and its association with cognitive performance and impairment in old age. J Am Geriatr Soc 2010, 58:1322-1326.
65. Almeida OP, Hulse GK, Lawrence D, Flicker L Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction 2002, 97:15-28.
66. Anstey KJ, von Sanden C, Salim A, O'Kearney R Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007, 166:367-378.
67. Cataldo JK, Prochaska JJ, Glantz SA Cigarette smoking is a risk factor for Alzheimer's disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis 2010, 19:465-480.
68. Peters R, Poulter R, Warner J, Beckett N, Burch L, Bulpitt C Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr 2008, 8:36.
69. Jha P, Ranson MK, Nguyen SN, Yach D Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health 2002, 92:1002-1026.
70. Storr CL, Cheng H, Alonso J, et al. Smoking estimates from around the world: data from the first 17 participating countries in the World Mental Health Survey Consortium. Tobacco Control 2010, 19:65-74.
71. Vital signs: current cigarette smoking among adults aged >or=18 years-United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59:1135-1140. Centers for Disease Control and Prevention (CDC).
72. Valenzuela MJ Brain reserve and the prevention of dementia. Curr Opin Psychiatry 2008, 21:296-302.
73. Caamano-Isorna F, Corral M, Montes-Martinez A, Takkouche B Education and dementia: a meta-analytic study. Neuroepidemiology 2006, 26:226-232.
74. Ball K, Berch DB, Helmers KF, et al. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA 2002, 288:2271-2281.
75. Willis SL, Tennstedt SL, Marsiske M, et al. Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA 2006, 296:2805-2814.
76. Papp KV, Walsh SJ, Snyder PJ Immediate and delayed effects of cognitive interventions in healthy elderly: a review of current literature and future directions. Alzheimers Dement 2009, 5:50-60.
77. Martin M, Clare L, Altgassen AM, Cameron MH, Zehnder F Cognition-based interventions for healthy older people and people with mild cognitive impairment. Cochrane Database Syst Rev 2011, 1. CD006220.
78. Barro RJ, Lee J-W A new data set of educational attainment in the world, 1950-2010: NBER Working Paper No. 15902. The National Bureau of Economic Research (accessed Jan 19, 2011). http://www.nber.org/papers/w15902.
79. Stern Y What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002, 8:448-460.
80. Yaffe K, Weston A, Graff-Radford NR, et al. Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA 2011, 305:261-266.
81. Barnes DE, Haight TJ, Mehta KM, Carlson MC, Kuller LH, Tager IB Secondhand smoke, vascular disease, and dementia incidence: findings from the cardiovascular health cognition study. Am J Epidemiol 2010, 171:292-302.
82. Swan GE, Lessov-Schlaggar CN The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev 2007, 17:259-273.
83. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA 1997, 277:813-817.
84. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003, 348:1215-1222.
85. Barnes DE, Whitmer RA, Yaffe K Physical activity and dementia: the need for prevention trials. Exerc Sport Sci Rev 2007, 35:24-29.
86. High Blood Pressure (accessed Jan 13, 2011). http://www.cdc.gov/bloodpressure/index.htm.
87. Overweight and Obesity (accessed Jan 13, 2011). http://www.cdc.gov/obesity/index.html.
88. Cotman CW, Berchtold NC, Christie LA Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007, 30:464-472.
89. Voss MW, Prakash RS, Erickson KI, et al. Plasticity of brain networks in a randomized intervention trial of exercise training in older adults. Front Aging Neurosci 2010, 2:32.
90. Middleton LE, Yaffe K Targets for the prevention of dementia. J Alzheimers Dis 2010, 20:915-924.
91. Dotson VM, Beydoun MA, Zonderman AB Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 2010, 75:27-34.
92. Wilson RS, Arnold SE, Beck TL, Bienias JL, Bennett DA Change in depressive symptoms during the prodromal phase of Alzheimer disease. Arch Gen Psychiatry 2008, 65:439-445.
93. Alexopoulos GS Vascular disease, depression, and dementia. J Am Geriatr Soc 2003, 51:1178-1180.
94. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006, 63:273-279.
95. Luchsinger JA, Gustafson DR Adiposity and Alzheimer's disease. Curr Opin Clin Nutr Metab Care 2009, 12:15-21.
96. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004, 63:658-663.
97. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004, 292:2237-2242.
98. Yaffe K Metabolic syndrome and cognitive disorders: is the sum greater than its parts?. Alzheimer Dis Assoc Dis 2007, 21:167-171.
99. US Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute, National High Blood Pressure Education Program. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, 2003.
100. Scarmeas N, Stern Y, Mayeux R, Luchsinger JA Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol 2006, 63:1709-1717.
101. Sofi F, Abbate R, Gensini GF, Casini A Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010, 92:1189-1196.